Horizon Pharma PLC | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
149,005.00
263,603.00
39,532.00
166,834.00
410,526.00
74,187
Depreciation, Depletion & Amortization
9,310.00
34,009.00
138,343.00
221,837.00
283,415.00
275,729
Other Funds
18,675.00
9,385.00
3,024.00
5,539.00
26,533.00
201,650
Funds from Operations
47,835.00
13,490.00
193,036.00
233,689.00
134,220.00
338,701
Changes in Working Capital
6,452.00
14,059.00
4,130.00
135,767.00
145,988.00
144,158
Net Operating Cash Flow
54,287.00
27,549.00
197,166.00
369,456.00
280,208.00
194,543
Capital Expenditures
1,198.00
3,500.00
7,156.00
15,731.00
4,334.00
Sale of Fixed Assets & Businesses
-
-
-
-
69,371.00
Purchase/Sale of Investments
-
-
34,469.00
3,879.00
-
Net Investing Cash Flow
36,135.00
227,720.00
995,048.00
1,375,881.00
102,183.00
Issuance/Reduction of Debt, Net
78,754.00
286,966.00
939,027.00
652,190.00
74,895.00
Net Financing Cash Flow
66,716.00
338,285.00
1,439,481.00
657,074.00
58,408.00
Net Change in Cash
23,607.00
138,327.00
640,809.00
350,561.00
241,749.00
Free Cash Flow
55,485.00
24,049.00
190,010.00
353,725.00
275,874.00
Deferred Taxes & Investment Tax Credit
1,186.00
7,516.00
180,549.00
65,561.00
132,231.00
64,491
Net Assets from Acquisitions
35,000.00
224,220.00
1,022,361.00
1,356,271.00
167,220.00
Other Sources
63.00
-
-
-
-
Change in Capital Stock
6,637.00
41,934.00
503,478.00
10,423.00
10,046.00
Exchange Rate Effect
99.00
213.00
790.00
1,210.00
5,316.00
About Horizon Pharma
View Profile
